Older adults in aged care account for 30% of the population burden of hip fractures. Nutritional interventions to correct under nutrition reduce these debilitating fractures, perhaps partly by reducing falls and slowing deterioration in bone morphology. to determine whether a nutritional approach to fracture risk reduction in aged care homes is cost-effective. cost-effectiveness was estimated based on results from a prospective 2-year cluster-randomised controlled trial and secondary data. Intervention residents consumed a total of 3.5 daily servings of milk, yoghurt and/or cheese, resulting in 1,142 mg of calcium and 69 g of protein compared with the daily intakes of 700 mg of calcium and 58 g of protein consumed by the control group. fifty-six aged care homes. residents for 27 intervention (n = 3,313) and 29 control (n = 3,911) homes. ambulance, hospital, rehabilitation and residential care costs incurred by fracture were estimated. The incremental cost-effectiveness ratios per fracture averted within a 2-year time horizon were estimated from the Australian healthcare perspective applying a 5% discount rate on costs after the first year. intervention providing high-protein and high-calcium foods reduced fractures at a daily cost of AU$0.66 per resident. The base-case results showed that the intervention was cost-saving per fracture averted, with robust results in a variety of sensitivity and scenario analyses. Scaling the benefits of intervention equates to a saving of AU$66,780,000 annually in Australia and remained cost-saving up to a daily food expenditure of AU$1.07 per resident. averting hip and other non-vertebral fractures in aged care residents by restoring nutritional inadequacy of protein and calcium is cost-saving.
14 June 2024 in Nutrition, Metabolism and Cardiovascular Diseases
Correction of calcium and protein undernutrition using milk, yoghurt, and cheese in older adults in aged care homes is associated with reduced fractures and falls. However, these foods contain potentially atherogenic fats. We aimed to determine whether this intervention that increased dairy consumption to recommended levels adversely affects serum lipid profiles. This was a sub-group analysis of a 2-year cluster-randomised trial involving 60 aged care homes in Australia. Thirty intervention homes provided additional milk, yoghurt, and cheese on menus while 30 control homes continued with their usual menus. A sample of 159 intervention and 86 controls residents (69% female, median age 87.8 years) had dietary intakes recorded using plate waste analysis and fasting serum lipids measured at baseline and 12 months. Diagnosis of cardiovascular disease and use of relevant medications were determined from medical records. Outcome measures were serum total, HDL and LDL cholesterol and ApoA-1 & B. Intervention increased daily dairy servings from 1.9 ± 1.0 to 3.5 ± 1.4 (p < 0.001) while controls continued daily intakes of ≤2 servings daily (1.7 ± 1.0 to 2.0 ± 1.0 (p = 0.028). No group differences were observed for serum total cholesterol/high-density lipoprotein-C (TC/HDL-C) ratio, Apoprotein B/Apoprotein A-1 (ApoB/ApoA-1) ratio, low-density lipoprotein-C (LDL-C), non-HDL-C, or triglycerides (TGs) at 12 months. Among older adults in aged care homes, correcting insufficiency in intakes of calcium and protein using milk, yoghurt and cheese does not alter serum lipid levels, suggesting that this is a suitable intervention for reducing the risk of falls and fractures. Australian New Zealand Clinical Trials Registry (ACTRN12613000228785) 2012; https://www.anzctr.org.au.
Very low energy diets (VLEDs) contain <800 kcal/day and typically comprise formulated meal replacement products with adequate protein and micronutrients. Food-based VLEDs are an alternative approach, but it is uncertain whether they can provide adequate nutrition within an 800 kcal/day restriction. This analysis aimed to assess the nutritional adequacy of food-based VLEDs compared with formula VLEDs. A systematized literature review was conducted to identify balanced food-based VLEDs by searching five scientific databases from inception to 23 March 2023 and online sources between 1 and 7 May 2023. Ultimately, nine diets were analyzed for nutritional content and compared with Codex Alimentarius standards for formula foods, and Australian estimated average requirement and adequate intake (AI) for adults 19–50 years. Optifast® was used as a comparator. None of the VLEDs met all nutritional benchmarks. Three food-based diets had nutrient profiles similar to formula VLEDs, with one being adequate for all nutrients except thiamine, magnesium and zinc in men and iron in women. All VLEDs, including Optifast®, did not meet AI for dietary fiber, except one. In general, food-based VLEDs offered more fiber than Optifast®. In conclusion, food-based VLEDs were inadequate in certain micronutrients but offered more dietary fiber than formula VLEDs. These nutritional deficits do not preclude food-based VLEDs from being recommended, provided they are addressed.
Background/Objectives: The objective of this study was to evaluate the feasibility, acceptability, weight loss response, safety and preliminary clinical outcomes of a pragmatic 8-week food-based very-low-energy intervention in adults with obesity. Methods: In this prospective, single-arm study, 10 adults eligible for very-low-energy diet (VLED) therapy completed an 8-week food-based intervention targeting approximately 800 kcal/day with an accepted intake range up to 1000 kcal/day. Participants planned, purchased and prepared all foods, supported by dietary self-monitoring and fortnightly dietitian consultations. The primary feasibility outcomes were acceptability and weight loss response. The secondary outcomes included recruitment, retention and engagement. The exploratory outcomes included anthropometric measures, blood pressure, nutritional and biochemical markers, dietary quality, nutritional adequacy and adverse events. Results: All participants completed the intervention. Nine of 10 (90%) Food Acceptability Questionnaire (FAQ) scores met their prespecified item-level acceptability thresholds, while 90% (95%CI 55.5 to 99.7%) of participants achieved ≥5% weight loss. Mean weight loss was 10.8%. Attendance at study visits was 100% (95% CI 69.2 to 100%). Participants completed 93 ± 13% of expected food diary days with mean daily energy intakes of 842 ± 70 kcal/day. Statistically significant improvements were observed in anthropometric measures, blood pressure, total and LDL cholesterol and dietary quality. No clinically concerning changes in micronutrient or safety parameters were observed. Adverse events were predominantly mild to moderate. Conclusions: This pragmatic 8-week food-based very-low-energy intervention demonstrated encouraging feasibility outcomes, although challenges associated with eating out warrant further attention. Further evaluation in larger controlled trials is needed to assess its comparative effectiveness relative to traditional meal replacement VLEDs and longer-term outcomes.